NervGen Pharma Corp (NGEN) NPV

Sell:2.50 CADBuy:2.53 CADNo change

Prices delayed by at least 15 minutes
Sell:2.50 CAD
Buy:2.53 CAD
Change:No change
Prices delayed by at least 15 minutes
Sell:2.50 CAD
Buy:2.53 CAD
Change:No change
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 March 2024
PFP BIOSCIENCES HOLDINGS LLC10% Owner
Buy
Regular purchase transaction
2,879,1492.35 CAD6,766,000.15 CAD2,879,149
28 March 2024
William Joseph RadvakChairman of the Board
Buy
Regular purchase transaction
20,0002.35 CAD47,000.00 CAD1,407,500
28 March 2024
Harold Martin PunnettOther Level A
Buy
Regular purchase transaction
25,5322.35 CAD60,000.20 CAD1,125,532
28 March 2024
William James AdamsCFO
Buy
Regular purchase transaction
44,0702.35 CAD103,564.50 CAD155,820
28 March 2024
Michael (Mike) KellyPresident/CEO
Buy
Regular purchase transaction
143,9572.35 CAD338,298.95 CAD143,957
28 March 2024
Glenn Antony IvesDirector
Buy
Regular purchase transaction
8,5112.35 CAD20,000.85 CAD58,511
28 March 2024
John RuffoloDirector
Buy
Regular purchase transaction
42,5532.35 CAD99,999.55 CAD42,553
28 March 2024
Randall KayeDirector
Buy
Regular purchase transaction
10,0002.35 CAD23,500.00 CAD10,000
28 March 2024
Krista McKerracherDirector
Buy
Regular purchase transaction
5,7582.35 CAD13,531.30 CAD5,758
11 March 2024
Brian Eric BayleyIndependent Director
Sell
Regular sell transaction (market)
150,0003.00 CAD450,000.00 CAD300,000

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 March 2024
PFP BIOSCIENCES HOLDINGS LLC10% Owner
Buy
Regular purchase transaction
2,879,1492.35 CAD6,766,000.15 CAD2,879,149
11 March 2024
Brian Eric BayleyIndependent Director
Sell
Regular sell transaction (market)
150,0003.00 CAD450,000.00 CAD300,000
28 March 2024
Michael (Mike) KellyPresident/CEO
Buy
Regular purchase transaction
143,9572.35 CAD338,298.95 CAD143,957
28 March 2024
William James AdamsCFO
Buy
Regular purchase transaction
44,0702.35 CAD103,564.50 CAD155,820
28 March 2024
John RuffoloDirector
Buy
Regular purchase transaction
42,5532.35 CAD99,999.55 CAD42,553

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.